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Abstract
Background: Consensus guidelines support non-operative preventives for dental caries management; yet, their use in
practice is far from universal. The purpose of this study was to evaluate the effectiveness of non-operative anti-caries
agents in caries prevention among high caries risk adults at a university clinic where risk-based caries management is
emphasized.
Methods: This retrospective observational study drew data from the electronic patient records of non-edentulous
adult patients deemed to be at high risk for dental caries during baseline oral evaluations that were completed
between July 1, 2007 and December 31, 2012 at a dental university in the United States. We calculated and compared
adjusted mean estimates for the number of new decayed or restored teeth (DFT increment) from baseline to the next
completed oral evaluation (N = 2,724 patients with follow-up) across three categories of delivery of non-operative
anti-caries agents (e.g., high-concentration fluoride toothpaste, chlorhexidine rinse, xylitol products): never, at a
single appointment, or at ≥2 appointments ≥4 weeks apart. Estimates were adjusted for patient and provider
characteristics, baseline dental status, losses-to-follow-up, and follow-up time.
Results: Approximately half the patients did not receive any form of non-operative anti-caries agent. Most that
received anti-caries agents were given more than one type of product in combination. One-time delivery of anti-caries
agents was associated with a similar DFT increment as receiving no such therapy (difference in increment: -0.04;
95 % CI: -0.28, 0.21). However, repeated, spaced delivery of anti-caries agents was associated with approximately
one decayed or restored tooth prevented over 18 months for every three patients treated (difference in
increment: -0.35; 95 % CI: -0.65, -0.08).
Conclusions: These results lend evidence that repeatedly receiving anti-caries agents can reduce tooth decay
among high-risk patients engaged in regular dental care.
Keywords: Dental caries, Epidemiology, Caries management, Longitudinal studies, Health outcomes research
Background
Despite long-standing consensus supporting minimal
intervention and non-operative preventives for caries
management in dental practice [1], a prevention-
oriented strategy is far from reaching universal adoption:
for example, many dentists favor restoration placement
over non-operative therapy for enamel-confined lesions
[2–4]. In contrast to traditional reliance on surgical
means, a risk-based approach to the clinical manage-
ment of dental caries stresses individualized treatment
decisions based on patients’ behavioral and biological
characteristics, with an emphasis on caries prevention
and preservation of tooth structure [5–9].
Caries Management by Risk Assessment (CAMBRA)
is one approach that has been proposed for patient-spe-
cific caries management [6]. First, in a risk assess-
ment stage, the clinician is guided to categorize a
patient’s caries risk based on an overall assessment
of disease indicators, caries protective factors, and
caries predisposing factors [6]. For adults categorized
* Correspondence: benjamin.chaffee@ucsf.edu
1Center to Address Disparities in Children’s Oral Health, UCSF School of
Dentistry, 3333 California Street, Suite 495, San Francisco, CA 94143-1361,
USA
Full list of author information is available at the end of the article
© 2015 Chaffee et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Chaffee et al. BMC Oral Health  (2015) 15:111 
DOI 10.1186/s12903-015-0097-4
as high risk, CAMBRA clinical guidelines recom-
mend providing antibacterial therapy (e.g., chlorhexidine
or xylitol products) and remineralizing agents (e.g., high-
concentration fluoride toothpaste) to manage caries as a
disease process [10]. The CAMBRA approach has been
firmly adopted in the university clinic in which this study
was based.
Relatively few studies have evaluated the effectiveness
of non-operative anti-caries management among adults
at high caries risk. A recent randomized controlled trial
reported that combined antibacterial and fluoride pre-
ventive therapy could lower caries risk and suggested a
reduction in 2-year caries increment among initially
high-risk patients [11]. The widespread implementation
of electronic health records represents an opportunity to
evaluate the effectiveness of personalized treatments in
real practice [12, 13]. In two studies drawn from patient
datasets, counseling adult patients at high caries risk to
use fluoride toothpaste was associated with later classifi-
cation into a lower risk category in one study [14], but
in the other, fluoride therapy was not associated with
significantly lower caries increment [15].
In the present retrospective observational study, we
aimed to evaluate caries management outcomes based
on electronic patient records at a university clinic
where CAMBRA is emphasized: specifically, whether
caries increment would be reduced among high-risk
patients who received non-operative anti-caries agents.
We hypothesized that among initially high-risk individ-
uals, caries increment will be lowest among those patients
who received non-operative anti-caries agents repeatedly
over time.
Methods
Study design and population
This retrospective cohort study collected data from elec-
tronic patient records at the student dental clinic of the
University of California San Francisco (UCSF). The
UCSF Committee on Human Research (institutional re-
view board) granted ethical approval for the use of retro-
spective patient data to evaluate patient outcomes
according to existing clinical practices. The Committee
did not require that explicit informed consent be col-
lected for this investigation.
Eligible for analysis were any patients who completed
at least one full oral examination (new patient or recall)
between July 1, 2007 and December 31, 2012 and were
designated as high caries risk (Fig. 1). Excluded were any
patients lacking teeth (third molars not counted) or less
than 18 years of age. There were 11,990 high-risk pa-
tients fitting these criteria, of whom 2,724 completed at
least one follow-up examination at least 180 days after
baseline (Fig. 1).
We compared the number of newly decayed and re-
stored teeth (DFT increment, a count outcome) and
caries incidence (DFT increment >0, a dichotomous
outcome for having any newly affected teeth versus
none) from baseline to follow-up across three levels
of delivery of non-operative anti-caries agents (e.g.,
fluoride, chlorhexidine, and/or xylitol products): never,
at a single clinic visit, or at ≥2 visits ≥4 weeks apart.
Study variables
Patients designated as high caries risk were included in
this study. Student providers, under the guidance of
Fig. 1 Flow diagram for participant inclusion criteria, treatment category, and follow-up. Among clinic patients that completed an oral examination
during the study period, there were 2,724 eligible initially high-risk patients with a follow-up examination
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faculty dentists, had assigned baseline caries risk cat-
egories following CAMBRA guidelines, which were de-
veloped by an expert working group of clinicians and
research scientists [6, 16]. In the caries risk assessment
component of CAMBRA, a clinician classifies a patient’s
caries risk (i.e., low, moderate, high, or extreme) after
consideration of the balance between existing biological
predisposing factors (e.g., frequent between meal snack-
ing, heavy plaque on teeth, reduced saliva flow), caries
protective factors (e.g., fluoride exposure, use of chlor-
hexidine rinse), and disease indicators (e.g., cavitated le-
sions, recently placed restorations), collected on a
standard caries risk assessment form [6]. No rigid classi-
fication algorithm is used. Rather, the clinician assesses
the overall balance of predisposing and protective fac-
tors. The CAMBRA risk assessment approach has been
shown to stratify patients into risk categories of increas-
ing future caries activity, both among adults in a univer-
sity clinic [17] and among kindergarten children in
Hong Kong [18]. Extreme-risk patients were excluded
from the present analysis due to the relatively small
number of patients assigned this risk designation.
DFT increment was the number of teeth (non-third
molars) between baseline and follow-up recorded as hav-
ing new carious decay (excluding white spot, arrested,
and enamel-confined lesions, but including decay
around existing restorations and root caries) or new res-
torations (i.e., amalgam, composite, glass ionomer,
onlay/inlay, or crown, but excluding restorations placed
on teeth affected by abfraction, attrition, or erosion
without caries involvement), as retrieved from electronic
patient records using practice management software
(axiUm, Exan Group, Vancouver, Canada). Teeth with
planned restorative treatment or decay at baseline were
not counted in the DFT increment. To avoid including
teeth needing treatment only for periodontal, orthodon-
tic, or esthetic reasons, we excluded teeth designated for
extraction and veneers or crowns placed on anterior
teeth, unless caries was recorded. We made the reason-
able assumption that restorative treatment completed
within 180 days of baseline was in response to baseline
decay rather than new conditions for inclusion in DFT
increment. The threshold 180 days was chosen based on
observed patterns in the timing of treatments in the stu-
dent clinic and has been used elsewhere [15]. Analo-
gously, we did include restorations placed up to
180 days after follow-up in calculating DFT increment.
We defined three categories of non-operative anti-caries
therapy. Anti-caries therapy was defined as receiving any
anti-caries agent between baseline and follow-up, includ-
ing chlorhexidine rinse (0.12 % chlorhexidine gluconate),
topical fluoride (e.g., fluoride toothpaste at 5000 ppm F or
fluoride varnish), and xylitol products (e.g., mint-flavored
tablets). Clinic procedures recommend the use of a
combination of these products for high-risk individuals.
Categories for data analysis and comparison were: 1) none
(anti-caries agents never received); 2) one time (received
at a single patient visit, even if multiple agents were dis-
pensed); and 3) two or more times (≥2 visits, ≥4 weeks
apart). Patients that received anti-caries agents at more
than one visit but within a single 4-week period and who
did not received anti-caries agents again were categorized
as one-time delivery. We selected these categories to ap-
proximate never use, one-off dispensing, and continuing
use of anti-caries agents.
Confounding variables included baseline patient charac-
teristics: age (categorized as 18–34, 35–44, 45–54, 55–64,
and ≥65 years), sex, payer type (private dental insurance,
public dental benefits, or no insurance/cash), self-identi-
fied race/ethnicity (African American, Asian, Cauca-
sian, Hispanic/Latino, or other/declined to state),
number of teeth; and student provider characteristics:
program (4-year doctoral program or 2-year program
for internationally trained dentists) and year in train-
ing (final year or next-last year). We also adjusted for
number of decayed teeth at baseline, because baseline dis-
ease status may have influenced the decision to pursue
non-operative therapy. As a secondary analysis, we also
included patient characteristics recorded in the baseline
risk assessment form (all binary variables): radiographic
or visible dentin cavitation, heavy dental plaque, fre-
quent snacking (>3 times daily between meals), twice-
daily fluoride toothpaste, adequate saliva flow, and
living, working, or attending school in a fluoridated
community.
We performed an exploratory subgroup analysis, in
which we calculated the difference in DFT increment ac-
cording to category of non-operative anti-caries therapy
in different patient groups. We repeated the analysis to
calculate caries outcomes but restricted the population
to subgroups defined according to patient sex, payer
type (private dental insurance, public dental benefits, no
insurance/cash), and age (18–44 years, ≥45 years).
Statistical power
The sample size used in the main analysis was a result
of the number of eligible high-risk patients attending the
clinic from 2007–2012. Given 1,501 patients with
follow-up who received no anti-caries therapy and 323
who received therapy twice or more, the study would
have 80 % power to detect a 0.26 reduction in DFT in-
crement and 90 % power to detect a 0.30 reduction, as-
suming 1.75 DFT increment in the no therapy group
(standard deviation = 1.5, alpha threshold for statistical
significance = 0.05, two-tailed test). The study would
have 80 % power to detect a 0.87 ratio in DFT incre-
ment >0 between the two groups and 90 % power to
detect a ratio of 0.85, assuming 65 % of patients with
Chaffee et al. BMC Oral Health  (2015) 15:111 Page 3 of 8
DFT increment >0 in the no therapy group (alpha = 0.05,
two-tailed test).
Statistical approach
We calculated doubly-robust adjusted estimates for car-
ies outcomes according to categories of anti-caries ther-
apy using g-computation and inverse probability
treatment weighting in a combined approach [19]. This
technique has been described approachably in recent
publications [20, 21]. We fitted regression models for
caries outcomes (negative binomial model for DFT in-
crement and logistic model for DFT increment >0),
where anti-caries therapy category was the exposure
variable and baseline covariates were age, sex, race/
ethnicity, payer type, baseline number of teeth, base-
line number of decayed teeth, calendar year, provider
program, provider years in training, and follow-up time.
Models were used to predict adjusted marginal caries out-
comes under each category of anti-caries therapy received,
setting follow-up time to 18-months (548 days), the mean
value in the follow-up sample. Regression models were
weighted using inverse probability treatment weights to
enhance robustness to model misspecification and using
inverse probability censoring weights to account for losses
to follow-up from the baseline sample [19, 22]. We multi-
ply imputed missing baseline data (0.2 % of covariate data
among eligible participants) and averaged point estimates
over 25 imputations. Results were unchanged in a sensitiv-
ity analysis restricted to cases with complete baseline co-
variate data.
Estimates represent the expected DFT increment asso-
ciated with each level of anti-caries therapy under the
same distribution of participant characteristics that was
observed in the baseline population and with equal
follow-up time (18 months). As measures of association,
we computed the difference in DFT increment and ratio
in the percentage of patients with DFT increment >0,
given single or repeated delivery of anti-caries therapy,
as two separate pair-wise comparisons, each with respect
to no therapy received. We used the percentile bootstrap
method (3000 bootstrap re-samples) to obtain 95 % con-
fidence intervals (CI) and considered results to be statis-
tically significant at the 0.05 level if the 95 % CI for
measures of association excluded the null value. Ana-
lyses were performed using statistical software (Stata
13.1, StataCorp LP, College Station, United States and R
3.1.2, R Foundation for Statistical Computing, Vienna,
Austria). Study reporting followed the STROBE state-
ment [23] (Additional file 1) .
Results
Of the 11,990 patients categorized as high caries risk at
baseline in this clinic, nearly two-thirds lacked either
public or private dental benefits coverage, and most
racially/ethnically identified as non-Caucasian. Mean pa-
tient age was 46.2 years (SD: 17.0; range: 18–99). Pa-
tients who completed at least one follow-up visit were
more likely to be male, in a more mature age category,
identify as Caucasian, and have private or public dental
benefits than patients who did not complete any follow-
up visit (all P < 0.001; chi-square test); however, the base-
line and follow-up samples were practically similar in
the overall distributions of measured demographic char-
acteristics (Table 1). Mean follow-up time was 542 days.
Among the 2,724 patients with a follow-up examin-
ation, 55.1 % did not receive any non-operative anti-
caries agent (Fig. 1). Of those who did receive some
form of non-operative anti-caries agent, 68.8 % began
therapy within 30 days of the baseline visit and all
patients began therapy within 180 days of the baseline
visit. Of the 323 patients who received anti-caries
agents at two or more visits, 82.7 % were given more
than one type of agent. In this group, 83.0 % received







N = 11,990 N = 9,266 N = 2,724
Patient sex, %
Male 48.1 47.2 51.2
Female 51.9 52.8 48.8
Patient age, %
18–34 years 32.0 34.8 22.4
35–44 years 16.4 17.1 14.0
45–54 years 17.9 17.7 18.9
55–64 years 17.2 16.1 20.9
≥65 years 16.4 14.3 23.8
Patient payer type, %
Private insurance 14.8 13.8 18.1
Public program 21.0 20.1 24.3
Cash 64.2 66.1 57.6
Patient race/ethnicity, %
African American 10.5 10.7 9.5
Asian 13.6 13.5 13.9
Caucasian 43.4 41.8 49.1
Hispanic/Latino 17.8 18.3 15.9
Other or declined to state 14.7 15.7 11.5
Provider type, %
Doctoral 4-year program 77.7 77.8 77.5
International 2-year program 22.3 22.2 22.5
Provider year of training, %
Final year 47.9 47.5 49.2
Next-to-last year 52.1 52.5 50.8
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high-concentration (5000 ppm F) fluoride gel or tooth-
paste for home use, 67.2 % received chlorhexidine rinse
(0.12 % chlorhexidine gluconate), and 42.7 % received
xylitol-containing products (e.g., lozenges, mints, or chew-
ing gum). Those patients who received anti-caries agents
twice or more were more likely to be female, older,
and to receive dental benefits through a public pro-
gram (Table 2).
Among initially high-risk patients, receipt of anti-
caries agents at two or more appointments was associ-
ated with a statistically significant 19 % reduction in ad-
justed DFT increment over 18 months: 1.47 affected
teeth compared to 1.82 affected teeth in the no therapy
group (Table 3). However, one-time receipt of anti-caries
agents was not associated with a meaningful difference
in DFT increment compared to the group that received
no anti-caries agents (Table 3). Unlike DFT increment,
the percentage of patients with any new decay (DFT in-
crement >0) did not differ substantially across the three
groups, regardless of whether anti-caries agents were re-
ceived once or repeatedly (Table 3). These results were
not altered substantially in a secondary analysis that ad-
justed for additional baseline caries risk factors, prevent-
ive factors, and disease indicators: in this analysis, the
difference in DFT increment between receipt of anti-
caries agents at two or more visits versus none was -0.32
(95 % CI: -0.64, -0.02).
In an exploratory subgroup analysis, we assessed
whether the difference in DFT increment between receiv-
ing anti-caries agents twice or more and receiving no anti-
caries agents varied by patient characteristics (Fig. 2).
Notably, the reduction in DFT increment with repeated
anti-caries therapy was greatest among patients with pub-
lic dental benefits (difference in increment: -0.63), a group
that almost entirely comprised patients enrolled in the
state Medicaid dental program and who were offered anti-
caries products at no charge.
Discussion
This study was one of the few to evaluate caries out-
comes among high-risk adults following delivery of non-
operative preventives, and to our knowledge, the first
study to examine outcomes according to the frequency
with which preventives were received. Delivery of non-
operative anti-caries agents at multiple visits was associ-
ated with a 19 % reduction in DFT increment but no
statistically significant difference in the incidence of new
decay (DFT increment >0). This indicates that in high-
risk populations, anti-caries agents might be most useful
for reducing disease severity among caries affected indi-
viduals, as opposed to preventing caries entirely. In a re-
cently reported randomized controlled trial of high
caries risk adults, a combined antibacterial and fluoride
therapy intervention resulted in no difference in the
probability of having no incremental lesions in a zero-
inflated Poisson model but yielded a statistically signifi-
cant 24 % decrease in DMFS increment for the count
portion of the model [11]. Similarly, a community ran-
domized trial featuring fluoride varnish applications for
Aboriginal children in Australia reported a prevented
fraction for incremental lesions of approximately 30 %
Table 2 Study population characteristics and caries-related












N = 1,501 N = 900 N = 323
Patient sex, %
Male 52.6 50.5 46.3
Female 47.4 49.5 53.7
Patient age, %
18–44 years 37.1 38.2 27.2
≥45 years 62.9 61.8 72.8
Patient payer type, %
Private insurance 19.5 17.4 13.6
Public program 20.1 23.7 45.5
Cash 60.4 58.9 40.9
Patient race/ethnicity, %
African American 10.4 8.1 9.6
Asian 13.8 13.8 14.9
Caucasian 45.6 53.3 53.6
Hispanic/Latino 17.0 14.8 14.2
Other or declined to state 13.3 10.0 7.7
Provider type, %
Domestic 4-year program 73.0 82.4 84.5
International 2-year program 27.0 17.6 15.5
Provider year of training, %
Final year 50.6 48.2 45.2
Penultimate year 49.4 51.8 54.8
Radiographic or visible dentin
cavitation (baseline), %
45.3 44.7 41.8
Heavy plaque, % 59.1 56.1 58.4








Percentages listed in Table 2 exclude missing data. Extent of missing values
was lower for variables used in analysis (age: 0 %, race/ethnicity: 0 %, provider
type: 0 %, provider year of training: 0 %, payer type: 0.3 %, and sex: 0.4 %)
than for descriptive caries-risk variables (e.g., 36.5 % for radiographic or visible
dentin cavitation)
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but no statistically significant change in the prevalence
of children with ≥1 affected teeth [24].
In a similar retrospective study of administrative data
from two large US dental health plans, in one plan, a
formal recommendation for at-home fluoride treatment
for high-risk patients was associated with a non-
statistically significant 11 % reduction in caries incre-
ment [15]. However, in the second dental plan, high-risk
patients who received in-office topical fluoride demon-
strated higher caries increment than high-risk patients
given no therapy [15]. The authors speculated that den-
tists in this plan “further stratified” patients within the
high risk category, choosing to deliver preventive
therapy more often to a subset of high-risk patients
that they deemed even more likely to experience fu-
ture decay [15]. In the present study, we attempted to
account for such confounding by indication by adjust-
ing for the number of decayed teeth at baseline, and
in the adjusted analysis, we did observe a statistically
significant difference in DFT increment according to
therapy received.
While receipt of anti-caries agents at multiple visits
was associated with lower caries incidence, equivalent to
slightly more than one decayed/restored tooth prevented
over 18 months for every three patients treated, more
than half of these high-risk patients did not receive any
form of anti-caries agent. Whether less than universal
use of non-operative therapies reflects reticence on the
part of providers, patients, or both, our results suggest
that greater prevention could be achieved if non-
operative therapies were more widely utilized.
Notably, in the exploratory subgroup analysis, having
dental benefits through a public program was associated
with the greatest reduction in DFT increment with re-
peated delivery of anti-caries agents. A special arrange-
ment between the dental school and the administrator
of the state Medicaid dental program made it possible
for the university clinic to collect reimbursement for
risk-based preventive treatments and to provide them at
no charge to the patients who agreed to accept them.
Therefore, it is plausible that this reimbursement mech-
anism eased the way for more intensive preventive ther-
apy, both in terms of the frequency of delivery and the
number of different types of products provided, poten-
tially leading to a larger impact among these patients.
We had no measure of patient adherence to recom-
mended regimens for home-use anti-caries agents. We
speculate that poor patient adherence accounts for the
lack of anti-caries effectiveness associated with one-time
therapy. In contrast, we hypothesize that patients who
were dispensed agents on multiple occasions reflect ad-
herence patterns consistent with continuing home-use
and return for agent replenishment. The vast majority of
patients who received anti-caries agents on multiple
occasions were given more than one type of agent
(fluoride, xylitol, or chlorhexidine), which follows the
documented protocol emphasized in this clinic. Thus, it
was not possible to determine if any one agent was most










(DFT > 0), observed, %
Caries Incidence
(DFT > 0), adjusteda, %
Caries Incidence
Risk Ratioa (95 % CI)
Not received 1.76 1.82 reference 62.5 64.6 reference
Once 1.74 1.78 −0.04 (−0.29, 0.20) 62.8 64.2 0.99 (0.90, 1.07)
Twice or more 1.62 1.47 −0.35 (−0.65, −0.08) 61.3 62.5 0.97 (0.82, 1.06)
Abbreviations: CI confidence interval, DFT decayed, restored tooth index
Results based on 2,724 high caries risk patients with baseline caries risk assessment from 2007–2012
aAdjusted models account for patient age, sex, payer type, race/ethnicity, provider type and year in training, calendar year, baseline decayed teeth, baseline
number of teeth, losses-to-follow-up, and follow-up time
Fig. 2 Subgroup results. The figure demonstrates the adjusted 18-month difference in the number of decayed or restored teeth between patients
who received non-operative anti-caries agents repeatedly versus none received, according to subgroups defined by patient characteristics
Chaffee et al. BMC Oral Health  (2015) 15:111 Page 6 of 8
effective. The CAMBRA approach, which aims both to
decrease pathological factors (antibacterial therapy) and
simultaneously to enhance preventive or reparative ther-
apy (e.g., via high concentration fluoride product), likely
operates through multiple mechanistic pathways [25].
Harnessing routinely collected data from electronic
health records for clinical research presents challenges
but also promises to expand clinical research capacity
[26]. Data analyzed in this study were not collected spe-
cifically for use in research. For example, student pro-
viders did not undergo a specific calibration exercise in
caries detection, and there was no rigid methodology ap-
plied to treatment planning or caries risk assessment, al-
though all providers were part of the same educational
program, which teaches and emphasizes CAMBRA, and
at the time of this study, allowed for radiographic, visual,
and tactile methods to be used in caries detection. Also,
it is possible that our calculation of the DFT increment
included some restorations that were placed for reasons
other than dental caries, leading to an overestimation of
caries occurrence in all comparison groups. Such limita-
tions were partly balanced by access to a large analytic
sample that reflects realistic treatment decisions made
outside the context of a formal intervention study.
Further research is required to determine whether the
results observed in this study can be generalized beyond
this educational clinic, which predominantly serves
lower-income patients at high caries risk and in which
dental students are primarily responsible for diagnostic
and preventive care. Additionally, most patients ob-
served at baseline did not return to the clinic for a
follow-up examination, which could also decrease the
generalizeability of our findings. However, we imple-
mented inverse probability censoring weighting to ac-
count for differences in measured characteristics
between the baseline and follow-up samples. We did not
evaluate therapy outcomes among low, moderate, or ex-
treme risk patients due to the smaller number of pa-
tients in these categories, particularly in the extreme risk
group: a category marked by severe hypo-salivation and
for which guidelines suggest intensive preventive care in
multiple forms [10], which may surpass the level of
prevention provided to high-risk patients in this study.
Furthermore, consistent with CAMBRA guidelines, rela-
tively few low- and moderate-risk patients received anti-
caries agents.
We obtained adjusted outcome values through im-
plementation of a doubly-robust version of the g-
computation estimator, a technique rarely applied in
oral health research, despite increasingly common use
in epidemiology, generally [27, 28]. An attractive aspect of
this approach is the ease of interpretation: estimates take
the form of expected caries outcomes associated with each
category of interest under equal covariate distributions.
However, as with all observational studies, analyses must
account for confounding variables, and it is possible that
unmeasured factors could have affected the results.
Conclusions
This study represents one of the largest longitudinal
evaluations of clinical caries outcomes following risk-
based non-operative therapy. These findings suggest that
aggressive management with remineralization and/or
antibacterial agents can successfully reduce the severity
of dental caries in high-risk patients and supports the
use of such agents in caries management among individ-
uals seeking dental care.
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